{"data":[{"accessionNo":"0001623632-26-001550","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001314102","issuerName":"EyePoint","ticker":"EYPT","cusip":"30233G209","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"J. Christopher Donahue","reportingCik":null,"personType":"IN","sharesOwned":6934414,"percentOfClass":8.04,"filedAt":"2026-10-07"},{"accessionNo":"0001623632-26-001550","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001314102","issuerName":"EyePoint","ticker":"EYPT","cusip":"30233G209","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"Ann C. Donahue","reportingCik":null,"personType":"IN","sharesOwned":6934414,"percentOfClass":8.04,"filedAt":"2026-10-07"},{"accessionNo":"0001623632-26-001550","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001314102","issuerName":"EyePoint","ticker":"EYPT","cusip":"30233G209","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"Thomas R. Donahue","reportingCik":null,"personType":"IN","sharesOwned":6934414,"percentOfClass":8.04,"filedAt":"2026-10-07"},{"accessionNo":"0001623632-26-001550","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001314102","issuerName":"EyePoint","ticker":"EYPT","cusip":"30233G209","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"Voting Shares Irrevocable Trust","reportingCik":null,"personType":"OO","sharesOwned":6934414,"percentOfClass":8.04,"filedAt":"2026-10-07"},{"accessionNo":"0001623632-26-001550","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001314102","issuerName":"EyePoint","ticker":"EYPT","cusip":"30233G209","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"Federated Hermes, Inc.","reportingCik":null,"personType":"HC","sharesOwned":6934414,"percentOfClass":8.04,"filedAt":"2026-10-07"},{"accessionNo":"0001274173-26-000222","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EYEPOINT, INC.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock","eventDate":"2026-08-31","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":9366332,"percentOfClass":10.9,"filedAt":"2026-09-08"},{"accessionNo":"0001172661-26-003689","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001","eventDate":"2026-06-30","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":7000000,"percentOfClass":8.35,"filedAt":"2026-08-14"},{"accessionNo":"0001172661-26-003689","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001","eventDate":"2026-06-30","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":7000000,"percentOfClass":8.35,"filedAt":"2026-08-14"},{"accessionNo":"0000919574-26-004955","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":4790792,"percentOfClass":5.71,"filedAt":"2026-08-12"},{"accessionNo":"0000919574-26-004955","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":4790792,"percentOfClass":5.71,"filedAt":"2026-08-12"},{"accessionNo":"0000919574-26-004955","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":4790792,"percentOfClass":5.71,"filedAt":"2026-08-12"},{"accessionNo":"0002100119-26-001390","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint Inc","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":4223415,"percentOfClass":5.03,"filedAt":"2026-07-31"},{"accessionNo":"0002012383-26-002491","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001314102","issuerName":"EyePoint Pharmaceuticals, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":6430477,"percentOfClass":7.7,"filedAt":"2026-07-28"},{"accessionNo":"0001831942-26-000028","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001","eventDate":"2026-05-27","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4250000,"percentOfClass":5.1,"filedAt":"2026-06-03"},{"accessionNo":"0001831942-26-000028","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001","eventDate":"2026-05-27","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":4250000,"percentOfClass":5.1,"filedAt":"2026-06-03"},{"accessionNo":"0001831942-26-000028","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001","eventDate":"2026-05-27","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":4250000,"percentOfClass":5.1,"filedAt":"2026-06-03"},{"accessionNo":"0001831942-26-000028","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001","eventDate":"2026-05-27","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":4250000,"percentOfClass":5.1,"filedAt":"2026-06-03"},{"accessionNo":"0001104659-26-062616","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":3142437,"percentOfClass":3.8,"filedAt":"2026-05-15"},{"accessionNo":"0001104659-26-062616","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3142437,"percentOfClass":3.8,"filedAt":"2026-05-15"},{"accessionNo":"0001104659-26-062616","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":3142437,"percentOfClass":3.8,"filedAt":"2026-05-15"},{"accessionNo":"0001104659-26-062616","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":2769062,"percentOfClass":3.3,"filedAt":"2026-05-15"},{"accessionNo":"0000919574-26-002911","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":3300000,"percentOfClass":3.96,"filedAt":"2026-05-13"},{"accessionNo":"0000919574-26-002911","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":3300000,"percentOfClass":3.96,"filedAt":"2026-05-13"},{"accessionNo":"0000919574-26-002911","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":3300000,"percentOfClass":3.96,"filedAt":"2026-05-13"},{"accessionNo":"0000102909-26-001250","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001314102","issuerName":"EyePoint Inc","ticker":"EYPT","cusip":"30233G209","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0001104659-26-019104","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-17","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":4192261,"percentOfClass":5.1,"filedAt":"2026-02-24"},{"accessionNo":"0001104659-26-019104","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-17","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4192261,"percentOfClass":5.1,"filedAt":"2026-02-24"},{"accessionNo":"0001104659-26-019104","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-17","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":4192261,"percentOfClass":5.1,"filedAt":"2026-02-24"},{"accessionNo":"0001104659-26-019104","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-17","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":3694542,"percentOfClass":4.5,"filedAt":"2026-02-24"},{"accessionNo":"0001193125-26-054761","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001314102","issuerName":"Eyepoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":3572335,"percentOfClass":4.3,"filedAt":"2026-02-17"},{"accessionNo":"0001193125-26-054761","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001314102","issuerName":"Eyepoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3572335,"percentOfClass":4.3,"filedAt":"2026-02-17"},{"accessionNo":"0001193125-26-054761","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001314102","issuerName":"Eyepoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":3572335,"percentOfClass":4.3,"filedAt":"2026-02-17"},{"accessionNo":"0000902664-26-000905","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":4700000,"percentOfClass":5.68,"filedAt":"2026-02-12"},{"accessionNo":"0000902664-26-000905","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":4700000,"percentOfClass":5.68,"filedAt":"2026-02-12"},{"accessionNo":"0000902664-26-000905","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001314102","issuerName":"EyePoint, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":4700000,"percentOfClass":5.68,"filedAt":"2026-02-12"},{"accessionNo":"0000929638-25-004523","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001314102","issuerName":"EyePoint Pharmaceuticals, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-04","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA","sharesOwned":8265000,"percentOfClass":9.98,"filedAt":"2025-12-08"},{"accessionNo":"0000929638-25-004523","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001314102","issuerName":"EyePoint Pharmaceuticals, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-04","reportingPerson":"Chen Bihua","reportingCik":null,"personType":"IN,HC","sharesOwned":8265000,"percentOfClass":9.98,"filedAt":"2025-12-08"},{"accessionNo":"0000902664-25-004890","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001314102","issuerName":"EyePoint Pharmaceuticals, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":5559782,"percentOfClass":8.07,"filedAt":"2025-11-13"},{"accessionNo":"0000902664-25-004890","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001314102","issuerName":"EyePoint Pharmaceuticals, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":5559782,"percentOfClass":8.07,"filedAt":"2025-11-13"},{"accessionNo":"0000902664-25-004890","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001314102","issuerName":"EyePoint Pharmaceuticals, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":5559782,"percentOfClass":8.07,"filedAt":"2025-11-13"},{"accessionNo":"0002012383-25-002572","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001314102","issuerName":"EyePoint Pharmaceuticals, Inc.","ticker":"EYPT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4485402,"percentOfClass":6.5,"filedAt":"2025-10-17"}],"updatedAt":"2026-10-15T03:01:51.805Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}